Link of Audio Recording of Investor/Analyst Conference Call
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals disclosed the availability of an audio recording from its investor/analyst conference call held on May 18, 2026. The call covered the company's unaudited Q4 FY2026 results and audited FY2026 financial results. The company stated that a transcript will be released to the stock exchanges and uploaded on its website in due course. This is a routine regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements (Regulation 30). The actual content of the call with management commentary is not included in the filing itself.
The filing itself is administrative in nature — it simply links to an audio recording rather than providing the content. Shareholders and analysts will need to access the recording or transcript to assess any material guidance or commentary on future performance.